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were also found in humans (Fig. 1a). On the other hand, geno-
types GII.12, GII.3, GII.6 and GII.14 were not identiﬁed in the
environment, but only in humans. The remaining genotypes
were observed infrequently and GII.6 strains were sufﬁciently
distinct to preclude any epidemiological link (Fig. 1b).
Except for GGIV and GI.6 all genotypes identiﬁed in the
environment were also detected in humans. Failure to detect
GIV in humans could be explained by the fact that initial lab-
oratory diagnosis of NoVs in humans only included primers
for NoV GI and GII detection. The absence of genotypes
GII.6 and GII.14 in wastewater is probably due to their
lower prevalence in the population.
Interestingly, the diversity of NoV GGII strains in our
study was higher than in a contemporary French study [11]
based on outbreak surveillance, despite Luxembourg’s much
smaller population and shorter study duration. All six geno-
types and GII.4 sub-lineages detected in 245 NoV GGII asso-
ciated outbreaks in France were also found in our study.
Furthermore, genotypes GII.c/GII.12 and GII.14 were found
in the present study but not in the French one. This high-
lights the usefulness of sample collection in wastewater
plants and sporadic cases in obtaining a more complete pic-
ture of overall NoV circulation.
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Abstract
A human outbreak of West Nile virus (WNV) infections
occurred in 2010 in central Macedonia, northern Greece. Most
cases were observed close to four rivers forming a large Delta,
a major Mediterranean wetland. WNV lineage 2 sequences were
obtained from two pools of Culex pipiens mosquitoes trapped in
sites where encephalitis cases occurred a few days before the
trapping. The Greek strain showed the highest homology to
Hungarian and South African strains, differing from the Russian
WNV lineage 2 strain, which suggests that at least two lineage 2
strains have been introduced and established in Europe, causing
severe disease to humans.
Keywords: Greece, lineage 2, mosquito, outbreak, West Nile
virus
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West Nile virus (WNV) is a mosquito-transmitted ﬂavivirus,
which is maintained in an enzootic cycle between birds
(amplifying hosts) and ornithophilic mosquitoes (vectors),
mainly of the Culex species, while humans, horses and
other mammals are incidental hosts. Although the majority
of infections are either asymptomatic or mild febrile cases,
approximately 1% of them present with neurological mani-
festations, with elderly and immunocompromized persons
highly affected [1]. Since the 1990s WNV has become a
major public health concern, as sporadic cases and out-
breaks among humans and equines have been reported in
several Mediterranean regions [2,3]. The interest in WNV
increased after the large human outbreaks in Romania and
the United States [4–6]. WNV infections had never been
documented in Greece. However, WNV neutralizing anti-
bodies had been detected in 2007 in 4/392 residents of an
area close to the Axios Delta in northern Greece, which is
a major wetland and resting site for migratory birds [7].
This area proved to be the epicentre of the large outbreak
of WNV infections in central Macedonia, Greece, in sum-
mer 2010 [8]. The ﬁrst 10 cases had been diagnosed on 5
August; all of them were central nervous system infections
(encephalitis, meningitis and meningoencephalitis), and two
of them were accompanied by exanthema. By 2 September
2010, 148 neuroinvasive cases had been laboratory
diagnosed, and 15 of them were fatal; most cases
Pella
Gypsochori
Nea Santa
2010 Tele Atlas
62 Xλμ. 2010 Europa Technologies
US Dept of State Geographer
Image 2010 DigitalGlobe
Thessalonika
Kalamaria
εσσαλονíκη
Kαλαμαρıα
Imathia
Pieria
Larissa
Kilkis
Thessaloniki
Chalkidiki
FIG. 1. Map of northern Greece showing the areas where the mosquito collection was performed. Human cases of West Nile virus (WNV)
infection were observed in the same areas. Purple pins show the places (Nea Santa and Gypsochori) where WNV-positive mosquitoes were
detected.
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occurred in the Imathia, Kilkis, Pella, Pieria and Thessaloniki
prefectures [9].
During 9–31 August 2010, 3524 adult mosquitoes were
collected by using CO2 traps in the places where the cases
had been observed (Fig. 1). Traps were set as soon as
possible after the laboratory diagnosis of the cases. Among
the 3524 mosquitoes, 3232 were Culex spp., 226 Aedes spp.
and 66 Anopheles spp. Mosquitoes were pooled according to
the collection site, date and genus. Each pool consisted of
no more than 50 mosquitoes. Viral RNA was extracted
using the RNeasy mini kit (Qiagen, Hilden, Germany) and
RT-nested PCRs were performed using two sets of primers:
one set was theoretically able to detect all ﬂaviviruses, and
the second set was speciﬁc for WNV [10,11]. Bands of the
expected sizes (146 and 106 bp, respectively) were obtained
on two pools of Culex pipiens mosquitoes. Mosquitoes of the
ﬁrst positive pool (50 mosquitoes) were trapped during the
night of 10–11 August 2010 at Nea Santa, a village in the Kil-
kis prefecture, 27 km northeast of Thessaloniki
(4050¢30¢¢N, 2254¢52¢¢E), while mosquitoes of the second
positive pool (25 mosquitoes) were trapped during the night
of 26–27 August 2010 at Gypsochori, a village in the Pella
prefecture, 50 km northwest of Thessaloniki (4048¢20¢¢N,
2215¢7¢¢E) (Fig. 1). Encephalitis cases had been observed in
these places a few days before the mosquito collection;
WNV-speciﬁc IgM antibodies were detected by l-capture
ELISA (Focus Technologies, Cypress, CA, USA) in serum
and cerebrospinal ﬂuid samples taken on 9 August from the
patient in Nea Santa, while samples from the patient in Gyp-
sochori were taken on 17 August. Sequences of both mos-
quito pools were identical in both PCRs. Use of the BLAST
tool revealed that the Greek sequences belonged to WNV
lineage 2 strains, as they were identical to those derived
from a dead goshawk in Hungary in 2004 and from a fatal
human case in South Africa in 1989 [12,13]. A phylogenetic
tree based on a 146-nt fragment of the NS5 gene is seen in
Fig. 2 (similar clustering was seen using the 106-bp fragment;
the phylogenetic tree is not shown). The 146-nt sequence
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FIG. 2. Phylogenetic tree based on 146-nt fragment of the NS5 gene of WNV, constructed by using PHYLIP software with the neighbour-joining
method and Kimura 2-parameter distance matrix. Japanese encephalitis virus (JEV) was used as outgroup. The numbers at the nodes indicate
percentage bootstrap replicates of 100; values below 60% are not shown. Horizontal distances are proportional to the nucleotide differences.
The scale bar indicates 10% nucleotide sequence divergence. Sequences in the tree are indicated as GenBank accession number, strain name,
country. Strain of the present study is shown in bold.
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(Nea Santa-Greece-2010) was submitted to GenBank data-
base under the accession number HQ230576. Although the
phylogenetic analysis was based on a short genome fragment,
it is evident that the Russian WNV strain RebVLG07, iso-
lated during an outbreak in Volgograd, Russia, in 2007 [14],
forms a distinct subclade in the WNV lineage 2 strains, sug-
gesting that at least two different virus introductions from
Africa took place. Determination of nucleotide sequences of
a larger genome fragment or, even better, of the whole gen-
ome of the Greek strain, will give better insight into the
exact relation with other WNV strains, and will elucidate
the probable epidemiological links, with migratory birds play-
ing an important role.
The detection of WNV lineage 2 sequences in mosquitos
collected in two different sites, exactly where WNV enceph-
alitis cases had been diagnosed a few days before, gives
strong evidence that this strain might be associated with the
outbreak; the detection of WNV RNA in clinical samples will
conﬁrm the results. In addition, the possibility that a second
WNV strain may be co-circulating in the region cannot be
excluded. Recent outbreaks in Mediterranean countries and
in North America were caused by WNV lineage 1 strains.
Prior to 2004, lineage 2 strains were detected only in sub-
Saharian Africa and Madagascar. Several authors addressed
the pathogenicity of WNV lineage 2 strains in South Africa
in humans and horses [13, 15–17]. Because only a few cases
of neurological disease have been reported from S. Africa,
endemic lineage 2 strains were postulated to be of low viru-
lence; however, recent studies suggest that lineage 2 WNV
may be signiﬁcantly underestimated as a cause of neurologi-
cal disease in S. Africa [18]. In 2004 a WNV lineage 2 strain
was detected in birds in Hungary, and since then it has been
detected sporadically in Hungary and the eastern part of
Austria [12, 19]. Another lineage 2 strain was detected dur-
ing a WNV outbreak in Russia in 2007 [14]. The genetic dis-
tance between the two lineages is relatively high
(approximately 20% at nucleotide level), a fact that facilitates
the virus spread in susceptible populations, especially when
ecological factors are favourable.
Culex spp. is the most common species in Greece. Previ-
ous studies have shown that C. pipiens is the dominant and
endophilic species in rural areas in central Macedonia, and it
was being collected for many years by using the human bait
method (Mourelatos, personal observations). Testing of addi-
tional mosquito pools is still in progress in Greece, while
whole genome nucleotide determination procedures are
ongoing. Results of the present study, although preliminary,
suggest that WNV lineage 2 strains were imported into and
established in Europe and might be a great public health
threat for Europe or other continents.
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Abstract
In order to investigate the current and past activity of phlebo-
virus and ﬂavivirus in Kosovo, a seroprevalence study among
200 blood donors was performed. Positive results were
obtained for the phleboviruses TOSV and SFNV, and for a ﬂavi-
virus of the Japanese Encephalitis group. No positive results for
TBEV were observed.
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The last decades have been characterized by the emergence
in the human population of new infectious agents from ani-
mal reservoirs, but also by the epidemic resurgence of well-
known arboviral diseases, such as dengue, West Nile and
chikungunya fever [1,2].
Other arboviruses, such as the Toscana virus (TOSV) and
the tick-borne encephalitis virus (TBEV), are known to be
endemic in some European countries. TOSV is mainly found
in the Mediterranean basin, whereas TBEV, which is com-
monly found in central Europe, is expanding its activity area
[3,4]. West Nile virus (WNV), ﬁrstly identiﬁed in tropical
Africa, has emerged as a cause of outbreaks and sporadic
cases in several countries of central, eastern and Mediterra-
nean Europe [5,6].
Little is known about the circulation of these viruses in
the southern Balkans, with the exception of Greece and
Albania, where high seroprevalence of TOSV [3] and TBEV
[4], respectively, has been reported. To increase knowledge
about arbovirus circulation in this European sub-region, we
conducted a seroprevalence study of infection with phlebovi-
rus TOSV and ﬂaviviruses TBEV and WNV among blood
donors in Kosovo.
The study population was represented by blood donors
recruited in the Peja Hospital in north-western Kosovo. Of
the samples collected from the 301 candidate blood donors
screened for donation suitability between 1 January and 30
March 2005, 200 were randomly selected for the study.
Informed consent from each participant was obtained. Socio-
demographic information included age, gender, occupation,
education and area of residence (urban or rural). More
detailed information is provided in a previously published
study [7].
IgG against TOSV were investigated using an enzyme-
linked immunosorbent assay (ELISA) method, which has pre-
viously been described [8].
IgG antibodies against TBEV were detected using a
commercially available ELISA system (FSME IgG and IgM
Immunozym; Progen Biotech GMBH, Heidelberg, Germany).
A standard haemagglutination inhibition (HI) test for TBEV
and WNV was also performed [9]. HI tests were carried out
at pH 6.6, both for TBEV and WNV.
Samples with borderline and positive ELISA results for
TOSV were conﬁrmed using a Plaque Reduction Neutraliza-
tion Test (PRNT) for both TOSV and Sandﬂy Naples virus
(SFNV). Samples with high HI titres for TBEV or WNV were
also tested by PRNT [10].
Overall, 200 blood donors were investigated. Of them,
176 (88%) were male and 24 (12%) female. The median age
was 34 years (range, 18–62 years). Most participants (i.e.
142, 71.7%) were resident in rural areas, whereas 56 (28.3%)
1180 Clinical Microbiology and Infection, Volume 17 Number 8, August 2011 CMI
ª2011 The Authors
Clinical Microbiology and Infection ª2011 European Society of Clinical Microbiology and Infectious Diseases, CMI, 17, 1170–1193
